title: 10 commonly asked questions about Parkinson disease.
authors.affiliation: Department of Medicine, Faculty of Medicine, Chulalongkorn Comprehensive Movement Disorders Center, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand. rbhl@ucla.edu
authors.forename: Roongroj
authors.initials: R
authors.lastname: Bhidayasiri
authors.forename: Neil
authors.initials: N
authors.lastname: Brenden
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D018450:Disease Progression; D006801:Humans; D018696:Neuroprotective Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy
chemical_list: D000978:Antiparkinson Agents; D018696:Neuroprotective Agents